Celerion

Celerion expands to Singapore, names Chew Lan Chong executive director

Wednesday, June 4, 2014 01:25 PM

Celerion has expanded its formal business presence in Singapore, and has named Dr. Chew Lan Chong, MBBS, MRCS, MSc, executive director, medical research, of its new operations. Chong has 10 years of direct operational experience leading clinical pharmacology units.

More... »

WIRB Copernicus Group

Celerion, Korean Drug Development Fund collaborate on early phase clinical research

Wednesday, May 28, 2014 12:52 PM

Celerion and the Korean Drug Development Fund (KDDF) are collaborating to provide drug development experience and support for South Korea’s emerging drug discovery and development industry. 

More... »

CRF Health eCOA webinar series

Celerion opens at Seoul National University Hospital Clinical Trial Center

Wednesday, March 5, 2014 01:05 PM

Celerion, a provider of early clinical research, has expanded clinical operations to South Korea. Through a partnership with Seoul National University Hospital (SNUH), the new Asian office is located within the SNUH Clinical Trials Center, giving Celerion and its clients access to the 80-bed clinical research unit, particularly geared toward clinical pharmacology, oncology and pediatrics.

More... »

Parthenon Capital acquires Bracket

Friday, August 16, 2013 10:15 AM

Bracket, a specialty services provider, has been acquired by Parthenon Capital Partners, a growth-oriented private equity firm based in Boston and San Francisco, from Express Scripts Holding Company.

More... »

Celerion becomes first U.S.-based CRO to receive full AAHRPP accreditation

Monday, September 17, 2012 03:39 PM

Celerion, a provider of innovative early stage drug development solutions based in Lincoln, Neb., has been awarded full accreditation by the Association for the Accreditation Human Research Protection Programs (AAHRPP), an independent, non-profit accrediting body. Celerion's clinical facilities in Lincoln, Neptune, N.J. and Phoenix, Ariz., have achieved the milestone.

More... »

Akesis names John L. Capicchioni as new president

Thursday, May 31, 2012 12:34 PM

Akesis, a Lake Wylie, S.C.-based contract research firm specializing in phase II-IV clinical dermatology services and regulatory affairs consulting, has appointed John L. Capicchioni as its new president.

More... »

Celerion and Ricerca Biosciences form The Biosimilars Alliance

Thursday, March 1, 2012 11:23 AM

Lincoln, Neb.-based Celerion, a provider of early-stage drug development solutions, and Ricerca Biosciences, which offer discovery, preclinical and development services, have formed “The Biosimilars Alliance,” focused on preclinical and early clinical assessment of biologics manufactured by a new supplier.

More... »

Celerion receives ANVISA certification

Friday, June 10, 2011 11:33 AM

Lincoln, Neb.-based Celerion, a provider of early-stage drug development solutions, has announced that its clinical research operations in Belfast, Northern Ireland, and its clinical research and bioanalytical services operations in Lincoln, Neb., have been certified by the Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária – ANVISA). 

More... »

Celerion awarded LEED green building certification

Friday, May 27, 2011 10:55 AM

Celerion, a provider of early stage drug development solutions, has been awarded LEED Silver established by the U.S. Green Building Council and verified by the Green Building Certification Institute (GBCI). LEED is the nation’s program for the design, construction and operation of high performance green buildings.

More... »

Celerion gains membership in U.K. respiratory cluster

Tuesday, March 29, 2011 12:11 PM

CRO Celerion, which provides early-stage drug development solutions, said its Belfast facility has gained membership within the U.K. Respiratory Therapeutic Capability Cluster. Celerion will work with key decision makers in the U.K. to develop and execute phase I and IIa studies with targeted patient populations.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 21

As job growth in drug development sector soars, more employees are seeking new opportunities

U.K. study: Prisoners should have the right to participatein clinical trials on moral grounds, for healthcare access

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs